Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application.

3D bioprinting Bacterial vaginosis Female reproductive tract Lactobacillus crispatus Probiotics women's health

Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
05 2023
Historique:
received: 28 10 2022
revised: 06 04 2023
accepted: 13 04 2023
pmc-release: 01 05 2024
medline: 9 5 2023
pubmed: 20 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Bacterial vaginosis (BV) is characterized by low levels of lactobacilli and overgrowth of potential pathogens in the female genital tract. Current antibiotic treatments often fail to treat BV in a sustained manner, and > 50% of women experience recurrence within 6 months post-treatment. Recently, lactobacilli have shown promise for acting as probiotics by offering health benefits in BV. However, as with other active agents, probiotics often require intensive administration schedules incurring difficult user adherence. Three-dimensional (3D)-bioprinting enables fabrication of well-defined architectures with tunable release of active agents, including live mammalian cells, offering the potential for long-acting probiotic delivery. One promising bioink, gelatin alginate has been previously shown to provide structural stability, host compatibility, viable probiotic incorporation, and cellular nutrient diffusion. This study formulates and characterizes 3D-bioprinted Lactobacillus crispatus-containing gelatin alginate scaffolds for gynecologic applications. Different weight to volume (w/v) ratios of gelatin alginate were bioprinted to determine formulations with highest printing resolution, and different crosslinking reagents were evaluated for effect on scaffold integrity via mass loss and swelling measurements. Post-print viability, sustained-release, and vaginal keratinocyte cytotoxicity assays were conducted. A 10:2 (w/v) gelatin alginate formulation was selected based on line continuity and resolution, while degradation and swelling experiments demonstrated greatest structural stability with dual genipin and calcium crosslinking, showing minimal mass loss and swelling over 28 days. 3D-bioprinted L. crispatus-containing scaffolds demonstrated sustained release and proliferation of live bacteria over 28 days, without impacting viability of vaginal epithelial cells. This study provides in vitro evidence for 3D-bioprinted scaffolds as a novel strategy to sustain probiotic delivery with the ultimate goal of restoring vaginal lactobacilli following microbiological disturbances.

Identifiants

pubmed: 37076014
pii: S0168-3659(23)00273-0
doi: 10.1016/j.jconrel.2023.04.023
pmc: PMC10696519
mid: NIHMS1948405
pii:
doi:

Substances chimiques

Gelatin 9000-70-8
Alginates 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-560

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI168475
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Références

Int J Biol Macromol. 2020 Feb 1;144:560-567
pubmed: 31857163
New Microbiol. 2013 Jul;36(3):229-38
pubmed: 23912864
Int J Oral Sci. 2014 Dec;6(4):189-94
pubmed: 25257882
Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18380-5
pubmed: 24101503
Front Microbiol. 2022 Apr 28;13:877223
pubmed: 35572713
Clin Microbiol Infect. 2009 Jan;15(1):67-74
pubmed: 19046169
J Gynecol Obstet Hum Reprod. 2018 Feb;47(2):81-86
pubmed: 29196153
AAPS J. 2021 May 10;23(3):66
pubmed: 33973067
J Mech Behav Biomed Mater. 2018 Mar;79:150-157
pubmed: 29304429
Biofabrication. 2017 Nov 14;9(4):044107
pubmed: 28930091
Adv Drug Deliv Rev. 2015 Sep 15;92:105-22
pubmed: 26144995
Molecules. 2020 Feb 10;25(3):
pubmed: 32050529
BJOG. 2017 Jan;124(1):61-69
pubmed: 27396541
J Biomed Mater Res B Appl Biomater. 2011 Apr;97(1):58-65
pubmed: 21381191
Am J Obstet Gynecol. 1996 May;174(5):1618-21
pubmed: 9065140
Contraception. 1999 Feb;59(2):91-5
pubmed: 10361623
Biofabrication. 2019 Sep 13;11(4):045018
pubmed: 31370051
Int J Womens Health. 2011;3:295-305
pubmed: 21976983
J Mater Sci Mater Med. 2013 Dec;24(12):2719-27
pubmed: 23892484
J Infect Dis. 2006 Jun 1;193(11):1478-86
pubmed: 16652274
J Pharm Sci. 2018 Feb;107(2):638-646
pubmed: 28989018
Int J Pharm. 2022 Aug 25;624:121991
pubmed: 35809833
Int J Pharm. 2020 Nov 30;590:119867
pubmed: 32919001
J Infect Dis. 2010 Dec 15;202(12):1907-15
pubmed: 21067371
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):598-603
pubmed: 20018745
Arch Gynecol Obstet. 2021 Jan;303(1):37-45
pubmed: 33025086
Antiviral Res. 2010 Dec;88 Suppl 1:S30-9
pubmed: 21109066
Am J Obstet Gynecol. 2001 Aug;185(2):375-9
pubmed: 11518895
BMC Microbiol. 2009 Feb 11;9:35
pubmed: 19210794
Biotechnol Adv. 2016 Jul-Aug;34(4):422-434
pubmed: 26724184
N Engl J Med. 2020 May 14;382(20):1906-1915
pubmed: 32402161
Drug Dev Ind Pharm. 2015;41(9):1518-25
pubmed: 25265366
Biofabrication. 2012 Sep;4(3):035001
pubmed: 22728820
Ginekol Pol. 2020;91(7):412-416
pubmed: 32779162
ACS Synth Biol. 2017 Jul 21;6(7):1124-1130
pubmed: 28225616
Hum Reprod. 2016 Apr;31(4):795-803
pubmed: 26911864
Nano Lett. 2021 Feb 10;21(3):1352-1359
pubmed: 33508203
Sci Rep. 2016 Apr 19;6:24474
pubmed: 27091175
J Obstet Gynaecol. 2018 Jul;38(5):693-696
pubmed: 29526145
Macromol Biosci. 2023 Apr;23(4):e2200514
pubmed: 36662610
Res Microbiol. 2017 Nov - Dec;168(9-10):782-792
pubmed: 28435139
Cureus. 2020 Dec 29;12(12):e12362
pubmed: 33527045
PLoS One. 2016 Apr 19;11(4):e0153441
pubmed: 27093291
J Gastroenterol. 2009;44(1):26-46
pubmed: 19159071
Colloids Surf B Biointerfaces. 2019 Sep 1;181:1026-1034
pubmed: 31382330
Pharmaceutics. 2022 Sep 13;14(9):
pubmed: 36145685
Antimicrob Agents Chemother. 2014 May;58(5):2747-53
pubmed: 24566190
ACS Biomater Sci Eng. 2020 Mar 9;6(3):1776-1786
pubmed: 33455385
Mar Drugs. 2015 Dec 11;13(12):7314-38
pubmed: 26690453
Biofabrication. 2016 Sep 16;8(3):035020
pubmed: 27634915
Int J Biol Macromol. 2020 Apr 15;149:651-663
pubmed: 32006574
Pharm Dev Technol. 2017 Jun;22(4):551-561
pubmed: 27055376
Carbohydr Polym. 2021 May 15;260:117774
pubmed: 33712131
Int J Pharm. 2020 Sep 25;587:119659
pubmed: 32687973
Am J Obstet Gynecol. 2003 Jul;189(1):139-47
pubmed: 12861153
BMC Infect Dis. 2011 Jul 19;11:200
pubmed: 21771337
Int J Biol Macromol. 2018 Jun;112:737-744
pubmed: 29427684
J Biomed Mater Res A. 2013 May;101(5):1255-64
pubmed: 23015540
Obstet Gynecol. 1990 Jan;75(1):52-8
pubmed: 2296423
BMC Womens Health. 2008 Jan 15;8:3
pubmed: 18197974
Biofabrication. 2019 Sep 10;11(4):042001
pubmed: 31315105
Am J Obstet Gynecol. 1989 Sep;161(3):808-12
pubmed: 2782365
J Drug Target. 2018 Aug;26(7):533-550
pubmed: 29096548
Tissue Cell. 2023 Feb;80:101995
pubmed: 36512950
Reprod Sci. 2015 Aug;22(8):964-8
pubmed: 25670719
Biofabrication. 2020 Mar 11;12(2):025022
pubmed: 32050179
BMC Med. 2021 Sep 2;19(1):194
pubmed: 34470644
Zhonghua Fu Chan Ke Za Zhi. 2002 Oct;37(10):588-90
pubmed: 12487930
Int J Food Microbiol. 2004 Nov 15;96(3):307-13
pubmed: 15454321
Am J Reprod Immunol. 2010 Jul 1;64(1):38-57
pubmed: 20331587
Biomaterials. 2002 Dec;23(24):4827-32
pubmed: 12361622
BJOG. 2006 Dec;113(12):1419-25
pubmed: 17010117
Macromol Biosci. 2006 Aug 7;6(8):623-33
pubmed: 16881042
J Low Genit Tract Dis. 2014 Jan;18(1):79-86
pubmed: 24299970
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):406-7
pubmed: 3137044
N Engl J Med. 1988 Oct 13;319(15):972-8
pubmed: 3262199
Nano Lett. 2018 Dec 12;18(12):7448-7456
pubmed: 30403141
J Control Release. 2015 Jul 10;209:150-8
pubmed: 25913364
Biofabrication. 2018 Jun 29;10(3):034106
pubmed: 29923501
Adv Sci (Weinh). 2021 Mar 11;8(10):2003751
pubmed: 34026444
BMC Microbiol. 2009 Jun 02;9:116
pubmed: 19490622
Acta Obstet Gynecol Scand. 2008;87(3):360-5
pubmed: 18307078
Asian J Pharm Sci. 2020 Sep;15(5):529-557
pubmed: 33193859
Nat Commun. 2021 Nov 23;12(1):6600
pubmed: 34815411
APL Bioeng. 2021 Feb 04;5(1):011502
pubmed: 33564740
Int J Mol Sci. 2021 Feb 16;22(4):
pubmed: 33669209
Acta Biomater. 2016 Mar 01;32:170-177
pubmed: 26747979
Am J Obstet Gynecol. 2020 May;222(5):471.e1-471.e9
pubmed: 31654610
J Pharm Sci. 2014 Nov;103(11):3611-3620
pubmed: 25231193
Clin Infect Dis. 2003 Mar 1;36(5):663-8
pubmed: 12594649
J Clin Microbiol. 2011 Feb;49(2):735-6
pubmed: 21106793
Sex Transm Dis. 2004 Aug;31(8):488-91
pubmed: 15273582
Acta Biomater. 2014 Feb;10(2):630-40
pubmed: 24157694
Semin Fetal Neonatal Med. 2012 Feb;17(1):2-11
pubmed: 22137615
Clin Oral Investig. 2007 Dec;11(4):425-9
pubmed: 17574481
ACS Appl Bio Mater. 2021 Apr 19;4(4):2886-2906
pubmed: 35014383
Biomater Sci. 2018 May 1;6(5):915-946
pubmed: 29492503
Arch Gynecol Obstet. 2014 Mar;289(3):479-89
pubmed: 24170161
J Mater Chem B. 2022 Nov 9;10(43):8862-8874
pubmed: 35980231
Adv Drug Deliv Rev. 2018 Jul;132:270-295
pubmed: 30055210
Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:143-148
pubmed: 31901667
Biomaterials. 2020 Jan;226:119536
pubmed: 31648135
Pharmaceutics. 2019 Oct 03;11(10):
pubmed: 31623341
Expert Opin Pharmacother. 2010 Dec;11(18):2985-95
pubmed: 21080853
Obstet Gynecol. 2002 Sep;100(3):456-63
pubmed: 12220764
J Pharm Sci. 2012 Aug;101(8):2833-43
pubmed: 22619076
BMC Microbiol. 2019 Jan 14;19(1):13
pubmed: 30642259
BJOG. 2008 Oct;115(11):1369-74
pubmed: 18823487
Carbohydr Polym. 2014 Feb 15;102:901-11
pubmed: 24507362
J Assist Reprod Genet. 2021 Oct;38(10):2519-2541
pubmed: 34110573
ACS Macro Lett. 2022 Apr 19;11(4):452-459
pubmed: 35575323
Polymers (Basel). 2020 May 01;12(5):
pubmed: 32370046
ACS Synth Biol. 2019 Jul 19;8(7):1564-1567
pubmed: 31319670
Biomacromolecules. 2013 Sep 9;14(9):3214-22
pubmed: 23985031
J Womens Health (Larchmt). 2019 Sep;28(9):1218-1226
pubmed: 31403349
Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111866
pubmed: 33641888
J Agric Food Chem. 2018 Oct 17;66(41):10890-10897
pubmed: 30260640
Antimicrob Agents Chemother. 2014;58(4):2262-7
pubmed: 24492360
Appl Environ Microbiol. 2021 Apr 27;87(10):
pubmed: 33674429
Int J Pharm. 2021 Nov 20;609:121124
pubmed: 34597726
J Med Signals Sens. 2018 Jul-Sep;8(3):170-174
pubmed: 30181965
Trends Biotechnol. 2015 Jun;33(6):362-9
pubmed: 25887334
Polymers (Basel). 2021 Feb 27;13(5):
pubmed: 33673621
Microb Cell Fact. 2020 Nov 7;19(1):203
pubmed: 33160356
J Clin Microbiol. 1994 Jan;32(1):176-86
pubmed: 8126176
Sci Rep. 2018 May 22;8(1):8020
pubmed: 29789674
BJOG. 2020 Jan;127(2):287-299
pubmed: 31299136
J Pharm Pharmacol. 2019 Jul;71(7):1044-1054
pubmed: 30887519
J Control Release. 2014 Sep 28;190:500-14
pubmed: 24830303
Microbiology (Reading). 2016 Mar;162(3):466-475
pubmed: 26747455
ACS Synth Biol. 2018 May 18;7(5):1328-1337
pubmed: 29690761
Chonnam Med J. 2012 Dec;48(3):159-63
pubmed: 23323221
Int J Pharm. 2020 Oct 15;588:119733
pubmed: 32768529
Sex Transm Dis. 2020 Jul;47(7):441-446
pubmed: 32235174
Int J Environ Res Public Health. 2019 Oct 12;16(20):
pubmed: 31614736
J Mech Behav Biomed Mater. 2020 Mar;103:103524
pubmed: 31785543
Sex Transm Dis. 2011 Nov;38(11):1020-7
pubmed: 21992977
J Biomed Mater Res A. 2008 Mar 15;84(4):899-907
pubmed: 17647237
Sex Transm Dis. 2019 May;46(5):304-311
pubmed: 30624309
Arch Gynecol Obstet. 2016 Jan;293(1):101-107
pubmed: 26142892
Materials (Basel). 2019 Aug 22;12(17):
pubmed: 31443354
Obstet Gynecol. 2001 Feb;97(2):211-9
pubmed: 11165584
Front Microbiol. 2016 Jan 20;6:1528
pubmed: 26834706
Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):375-90
pubmed: 17241817
mBio. 2013 Aug 06;4(4):
pubmed: 23919998

Auteurs

Anthony J Kyser (AJ)

Department of Bioengineering, University of Louisville Speed School of Engineering, Louisville, KY 40202, USA. Electronic address: ajkyse01@louisville.edu.

Mohammadali Masigol (M)

Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA. Electronic address: m.masigol@louisville.edu.

Mohamed Y Mahmoud (MY)

Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA; Department of Toxicology and Forensic Medicine, Faculty of Veterinary Medicine, Cairo University, Egypt. Electronic address: myabde01@louisville.edu.

Mark Ryan (M)

Department of Bioengineering, University of Louisville Speed School of Engineering, Louisville, KY 40202, USA. Electronic address: mark.ryan@louisville.edu.

Warren G Lewis (WG)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, La Jolla, CA, USA; Glycobiology Research and Training Center, University of California San Diego, La Jolla, CA, USA. Electronic address: wglewis@ucsd.edu.

Amanda L Lewis (AL)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, La Jolla, CA, USA; Glycobiology Research and Training Center, University of California San Diego, La Jolla, CA, USA. Electronic address: a1lewis@ucsd.edu.

Hermann B Frieboes (HB)

Department of Bioengineering, University of Louisville Speed School of Engineering, Louisville, KY 40202, USA; Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; UofL Health - Brown Cancer Center, University of Louisville, KY 40202, USA. Electronic address: hbfrie01@louisville.edu.

Jill M Steinbach-Rankins (JM)

Department of Bioengineering, University of Louisville Speed School of Engineering, Louisville, KY 40202, USA; Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. Electronic address: jmstei01@louisville.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH